The cancer treatment paradigm is experiencing a fundamental shift as intratumoral therapies emerge as a groundbreaking approach to oncology care. By delivering therapeutic agents directly into tumor sites, these innovative treatments offer unprecedented precision and efficacy while minimizing systemic side effects that have long plagued traditional cancer therapies. Market Expansion and Growth Drivers The Intratumoral Read.